CVI Investments, Inc. 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:14 pm Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | CVI Investments, Inc. | 0 0.000% | -5,500,000 (Position Closed) | Filing |
| 2023-02-14 11:14 am Sale | 2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | CVI Investments, Inc. | 5,500,000 6.900% | -1,222,709 (-18.19%) | Filing |
| 2022-02-14 3:19 pm Purchase | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | CVI Investments, Inc. | 6,722,709 9.900% | 448,324 (+7.15%) | Filing |
| 2021-12-10 12:18 pm Purchase | 2021-12-02 | 13G | Esperion Therapeutics, Inc. ESPR | CVI Investments, Inc. | 6,274,385 9.900% | 6,274,385 (New Position) | Filing |